About Timber Pharmaceuticals Inc

Timber Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases. The Company's investigational therapies have proven mechanisms-of-action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing and control) and safety profiles. The Company is initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis (CI), facial angiofibromas (FAs) in tuberous sclerosis complex (TSC), and scleroderma.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -0.97$ per share.

The book value per share is 0.16$

Timber Pharmaceuticals Inc website

Create a solid portfolio with TMBR

Add TMBR to your portfolio and optimize it!


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -19M - -15M -0.97 - - 16M 0.16 -8M -1M -9M